Why Compare Wegovy Side Effects vs Mounjaro Pricing?
Wegovy Side Effects vs Mounjaro: Understanding UK Pricing Differences
When comparing Wegovy side effects vs Mounjaro, cost considerations often influence treatment decisions alongside clinical factors. EverydayMeds offers the UK's most competitive pricing structure, with Wegovy available from £79.99 for the 0.25mg starter dose using discount code FIRST40 for new customers. This transparent pricing model ensures you understand exactly what you'll pay without hidden fees or surprise charges.
The comparison between Wegovy side effects vs Mounjaro becomes more accessible when cost barriers are removed through our competitive pricing. Both treatments are prescription-only medicines requiring clinical assessment, but our streamlined process ensures you receive expert guidance on which option suits your individual circumstances. Our GPhC-registered pharmacy (#9012878) maintains the highest standards whilst offering prices that make weight management treatment accessible across the UK.
Complete Wegovy Pricing Structure and Bundle Savings
Understanding the full cost implications when comparing Wegovy side effects vs Mounjaro requires transparent pricing information. Our Wegovy pricing starts at £79.99 for 0.25mg, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. New customers use code FIRST40 at checkout, whilst returning customers apply DOSE25 to access these competitive rates.
Our bundle options provide additional convenience when considering Wegovy side effects vs Mounjaro long-term costs. The Intro Duo (0.25mg & 0.5mg) costs £169.99, covering your first 8 weeks of treatment, whilst the Ultimate Stability Trio provides three months of 2.4mg maintenance doses for £649.99. These bundles ensure consistent supply without the inconvenience of frequent reordering, supporting your treatment continuity whilst managing costs effectively.
Clinical Evidence: Wegovy Side Effects vs Mounjaro Research
Clinical trials provide essential context when comparing Wegovy side effects vs Mounjaro safety profiles. In the STEP 1 trial (Wilding et al., NEJM, 2021), patients taking Wegovy alongside diet and exercise experienced approximately 15% average weight loss at 68 weeks, with the most common side effects being mild to moderate gastrointestinal symptoms including nausea, diarrhoea, and constipation. These side effects typically occurred during dose escalation phases and often diminished over time.
When evaluating Wegovy side effects vs Mounjaro, it's important to note that both treatments work through similar mechanisms but with different receptor targets. Wegovy (semaglutide) acts specifically on GLP-1 receptors, whilst Mounjaro (tirzepatide) targets both GIP and GLP-1 receptors as a dual agonist. Both medications require careful clinical assessment to determine suitability based on individual health circumstances and potential side effect considerations.
How Wegovy Works and Common Side Effect Profile
Wegovy functions as a GLP-1 receptor agonist, mimicking a natural hormone that regulates blood sugar and appetite. This mechanism helps reduce hunger signals and promotes feelings of fullness after smaller meals, potentially reducing food cravings by acting on brain appetite centres. The treatment may help support weight management when used alongside a reduced-calorie diet and increased physical activity. Most patients tolerate Wegovy well, though some experience mild gastrointestinal side effects during initial treatment phases. These effects often improve as the body adjusts to the medication through the carefully structured dose escalation protocol.
Streamlined Ordering Process for Both Treatments
Accessing either treatment when comparing Wegovy side effects vs Mounjaro begins with our 3-minute online clinical assessment, designed to gather essential health information safely and efficiently. Our qualified prescribers review your assessment within 3 working days as standard, or within 24 hours using our express service for urgent requirements. Once approved, your medication is dispatched via next-day cold-chain delivery, maintaining the strict temperature control required for these prescription-only medicines. Our GPhC-registered pharmacy (#9012878) ensures all medications meet pharmaceutical standards throughout the supply chain. This process provides peace of mind that your treatment comparison between Wegovy side effects vs Mounjaro is handled by qualified healthcare professionals.
Storage Requirements and Practical Considerations
Storage requirements differ slightly when comparing Wegovy side effects vs Mounjaro practically. Wegovy must be stored in the fridge at 2-8°C before first use, but offers a significant travel advantage with up to 6 weeks storage at room temperature below 30°C once removed from refrigeration. This compares favourably to Mounjaro's 21-day room temperature limit, providing greater flexibility for travel or lifestyle requirements. The FlexTouch pen design makes weekly injections straightforward, with clear dose escalation from 0.25mg through to the 2.4mg maintenance dose over 17 weeks. Both treatments require commitment to the full dose escalation schedule to minimise side effects whilst maximising treatment effectiveness.
Side Effect Management and Cost-Effective Treatment Access
Managing potential side effects becomes more achievable when treatment access isn't limited by cost barriers. Our competitive Wegovy pricing ensures that patients can maintain consistent treatment throughout the dose escalation period, which is crucial for minimising gastrointestinal side effects. Starting at the lowest dose and gradually increasing allows the body to adjust naturally, reducing the likelihood of treatment discontinuation due to side effects.
The comparison of Wegovy side effects vs Mounjaro costs extends beyond initial pricing to include ongoing prescriber support and convenience factors. Our clinical team remains available to discuss any concerns about side effects or treatment progress, ensuring that your chosen treatment continues to meet your needs effectively. This ongoing support adds significant value to the treatment cost, providing reassurance that side effect management is part of the comprehensive service.
Expert Guidance and Treatment Selection
Making an informed choice between Wegovy side effects vs Mounjaro requires expert clinical guidance rather than cost considerations alone. Our qualified prescribers assess your individual health circumstances, medical history, and treatment goals to recommend the most appropriate option. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your specific requirements and tolerance for potential side effects. The clinical assessment process ensures that price considerations don't override safety requirements, providing the optimal balance between affordability and appropriate care. With transparent pricing and expert guidance, you can confidently select the treatment that offers the best combination of effectiveness, tolerability, and value for your individual circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
